ÂÜÀòÂÒÂ×

Christoffer Jensen is an experienced medical professional with a robust background in medical affairs and strategy across various therapeutic areas. Currently serving as Medical Director at Jazz Pharmaceuticals since April 2022, Christoffer previously held prominent roles such as Head of Neurology, Medical Strategy & Communication at Lundbeck and Medical Director at Akcea Therapeutics, focusing on ultra rare diseases. With additional experience as Director of Medical Affairs at GSK and Nordic Medical Director at Grünenthal Group, Christoffer has also contributed significantly to the fields of neurology, oncology, and rare diseases. Early career roles include leading corporate communication efforts at Takeda Pharmaceuticals and healthcare consultancy at Burson-Marsteller. Christoffer holds a Doctor of Medicine from the University of Copenhagen and a Bachelor of Commerce in Business Management from Copenhagen Business School.